Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[cell line]	Characteristics[ethnicity]	Characteristics[age]	Characteristics[sex]	Characteristics[desease]	Characteristics[developmental stage]	Characteristics[individual]	comment[data file]	comment[associated file uri]	comment[fraction identifier]	comment[biological replicate]	comment [cleavage agent details]	comment [cleavage agent details]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[label]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	Characteristics[sort]	Material Type
Sample 1	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_1.raw	1	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	1	
Sample 2	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_2.raw	2	NA	NE=Lys-C;AC=MS:1001310	NE=Trypsin；AC=MS:1001252	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:66;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	2	
Sample 3	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_3.raw	3	NA	NE=Lys-C;AC=MS:1001311	NE=Trypsin；AC=MS:1001253	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:65;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	3	
Sample 4	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_4.raw	4	NA	NE=Lys-C;AC=MS:1001312	NE=Trypsin；AC=MS:1001254	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:64;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	4	
Sample 5	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_5.raw	5	NA	NE=Lys-C;AC=MS:1001313	NE=Trypsin；AC=MS:1001255	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:63;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	5	
Sample 6	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_6.raw	6	NA	NE=Lys-C;AC=MS:1001314	NE=Trypsin；AC=MS:1001256	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:62;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	6	
Sample 7	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_7.raw	7	NA	NE=Lys-C;AC=MS:1001315	NE=Trypsin；AC=MS:1001257	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:61;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	7	
Sample 8	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_8.raw	8	NA	NE=Lys-C;AC=MS:1001316	NE=Trypsin；AC=MS:1001258	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:60;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	8	
Sample 9	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_9.raw	9	NA	NE=Lys-C;AC=MS:1001317	NE=Trypsin；AC=MS:1001259	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:59;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	9	
Sample 10	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_10.raw	10	NA	NE=Lys-C;AC=MS:1001318	NE=Trypsin；AC=MS:1001260	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:58;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	10	
Sample 11	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_11.raw	11	NA	NE=Lys-C;AC=MS:1001319	NE=Trypsin；AC=MS:1001261	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:57;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	11	
Sample 12	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_12.raw	12	NA	NE=Lys-C;AC=MS:1001320	NE=Trypsin；AC=MS:1001262	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:56;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	12	
Sample 13	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_13.raw	13	NA	NE=Lys-C;AC=MS:1001321	NE=Trypsin；AC=MS:1001263	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:55;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	13	
Sample 14	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_14.raw	14	NA	NE=Lys-C;AC=MS:1001322	NE=Trypsin；AC=MS:1001264	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:54;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	14	
Sample 15	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_15.raw	15	NA	NE=Lys-C;AC=MS:1001323	NE=Trypsin；AC=MS:1001265	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:53;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	15	
Sample 16	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_16.raw	16	NA	NE=Lys-C;AC=MS:1001324	NE=Trypsin；AC=MS:1001266	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:52;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	16	
Sample 17	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_17.raw	17	NA	NE=Lys-C;AC=MS:1001325	NE=Trypsin；AC=MS:1001267	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:51;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	17	
Sample 18	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_18.raw	18	NA	NE=Lys-C;AC=MS:1001326	NE=Trypsin；AC=MS:1001268	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:50;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	18	
Sample 19	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_19.raw	19	NA	NE=Lys-C;AC=MS:1001327	NE=Trypsin；AC=MS:1001269	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:49;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	19	
Sample 20	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_20.raw	20	NA	NE=Lys-C;AC=MS:1001328	NE=Trypsin；AC=MS:1001270	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:48;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	20	
Sample 21	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_21.raw	21	NA	NE=Lys-C;AC=MS:1001329	NE=Trypsin；AC=MS:1001271	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:47;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	21	
Sample 22	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_22.raw	22	NA	NE=Lys-C;AC=MS:1001330	NE=Trypsin；AC=MS:1001272	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:46;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	22	
Sample 23	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_23.raw	23	NA	NE=Lys-C;AC=MS:1001331	NE=Trypsin；AC=MS:1001273	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:45;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	23	
Sample 24	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_24.raw	24	NA	NE=Lys-C;AC=MS:1001332	NE=Trypsin；AC=MS:1001274	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:44;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	24	
Sample 25	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_25.raw	25	NA	NE=Lys-C;AC=MS:1001333	NE=Trypsin；AC=MS:1001275	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:43;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	25	
Sample 26	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_26.raw	26	NA	NE=Lys-C;AC=MS:1001334	NE=Trypsin；AC=MS:1001276	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:42;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	26	
Sample 27	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_27.raw	27	NA	NE=Lys-C;AC=MS:1001335	NE=Trypsin；AC=MS:1001277	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:41;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	27	
Sample 28	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_28.raw	28	NA	NE=Lys-C;AC=MS:1001336	NE=Trypsin；AC=MS:1001278	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:40;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	28	
Sample 29	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_29.raw	29	NA	NE=Lys-C;AC=MS:1001337	NE=Trypsin；AC=MS:1001279	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:39;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	29	
Sample 30	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_30.raw	30	NA	NE=Lys-C;AC=MS:1001338	NE=Trypsin；AC=MS:1001280	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:38;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	30	
Sample 31	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_31.raw	31	NA	NE=Lys-C;AC=MS:1001339	NE=Trypsin；AC=MS:1001281	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:37;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	31	
Sample 32	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_32.raw	32	NA	NE=Lys-C;AC=MS:1001340	NE=Trypsin；AC=MS:1001282	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:36;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	32	
Sample 33	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_33.raw	33	NA	NE=Lys-C;AC=MS:1001341	NE=Trypsin；AC=MS:1001283	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:35;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	33	
Sample 34	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_34.raw	34	NA	NE=Lys-C;AC=MS:1001342	NE=Trypsin；AC=MS:1001284	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:34;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	34	
Sample 35	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_35.raw	35	NA	NE=Lys-C;AC=MS:1001343	NE=Trypsin；AC=MS:1001285	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:33;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	35	
Sample 36	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_36.raw	36	NA	NE=Lys-C;AC=MS:1001344	NE=Trypsin；AC=MS:1001286	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:32;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	36	
Sample 37	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_37.raw	37	NA	NE=Lys-C;AC=MS:1001345	NE=Trypsin；AC=MS:1001287	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:31;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	37	
Sample 38	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_38.raw	38	NA	NE=Lys-C;AC=MS:1001346	NE=Trypsin；AC=MS:1001288	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:30;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	38	
Sample 39	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_39.raw	39	NA	NE=Lys-C;AC=MS:1001347	NE=Trypsin；AC=MS:1001289	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:29;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	39	
Sample 40	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_40.raw	40	NA	NE=Lys-C;AC=MS:1001348	NE=Trypsin；AC=MS:1001290	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:28;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	40	
Sample 41	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_41.raw	41	NA	NE=Lys-C;AC=MS:1001349	NE=Trypsin；AC=MS:1001291	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:27;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	41	
Sample 42	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_42.raw	42	NA	NE=Lys-C;AC=MS:1001350	NE=Trypsin；AC=MS:1001292	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:26;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	42	
Sample 43	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_43.raw	43	NA	NE=Lys-C;AC=MS:1001351	NE=Trypsin；AC=MS:1001293	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:25;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	43	
Sample 44	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_44.raw	44	NA	NE=Lys-C;AC=MS:1001352	NE=Trypsin；AC=MS:1001294	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:24;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	44	
Sample 45	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_45.raw	45	NA	NE=Lys-C;AC=MS:1001353	NE=Trypsin；AC=MS:1001295	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:23;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	45	
Sample 46	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_46.raw	46	NA	NE=Lys-C;AC=MS:1001354	NE=Trypsin；AC=MS:1001296	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:22;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	46	
Sample 47	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_47.raw	47	NA	NE=Lys-C;AC=MS:1001355	NE=Trypsin；AC=MS:1001297	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:21;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	47	
Sample 48	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_48.raw	48	NA	NE=Lys-C;AC=MS:1001356	NE=Trypsin；AC=MS:1001298	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:20;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	48	
Sample 49	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_49.raw	49	NA	NE=Lys-C;AC=MS:1001357	NE=Trypsin；AC=MS:1001299	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:19;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	49	
Sample 50	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_50.raw	50	NA	NE=Lys-C;AC=MS:1001358	NE=Trypsin；AC=MS:1001300	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:18;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	50	
Sample 51	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_51.raw	51	NA	NE=Lys-C;AC=MS:1001359	NE=Trypsin；AC=MS:1001301	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:17;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	51	
Sample 52	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_52.raw	52	NA	NE=Lys-C;AC=MS:1001360	NE=Trypsin；AC=MS:1001302	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:16;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	52	
Sample 53	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_53.raw	53	NA	NE=Lys-C;AC=MS:1001361	NE=Trypsin；AC=MS:1001303	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:15;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	53	
Sample 54	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_54.raw	54	NA	NE=Lys-C;AC=MS:1001362	NE=Trypsin；AC=MS:1001304	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:14;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	54	
Sample 55	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_55.raw	55	NA	NE=Lys-C;AC=MS:1001363	NE=Trypsin；AC=MS:1001305	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:13;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	55	
Sample 56	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_56.raw	56	NA	NE=Lys-C;AC=MS:1001364	NE=Trypsin；AC=MS:1001306	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:12;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	56	
Sample 57	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_57.raw	57	NA	NE=Lys-C;AC=MS:1001365	NE=Trypsin；AC=MS:1001307	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:11;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	57	
Sample 58	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_58.raw	58	NA	NE=Lys-C;AC=MS:1001366	NE=Trypsin；AC=MS:1001308	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:10;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	58	
Sample 59	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_59.raw	59	NA	NE=Lys-C;AC=MS:1001367	NE=Trypsin；AC=MS:1001309	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:9;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	59	
Sample 60	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_60.raw	60	NA	NE=Lys-C;AC=MS:1001368	NE=Trypsin；AC=MS:1001310	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:8;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	60	
Sample 61	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_61.raw	61	NA	NE=Lys-C;AC=MS:1001369	NE=Trypsin；AC=MS:1001311	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:7;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	61	
Sample 62	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_62_150118230431.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_62_150118230431.raw	62	NA	NE=Lys-C;AC=MS:1001370	NE=Trypsin；AC=MS:1001312	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:6;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	62	
Sample 63	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_63.raw	63	NA	NE=Lys-C;AC=MS:1001371	NE=Trypsin；AC=MS:1001313	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:5;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	63	
Sample 64	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_64.raw	64	NA	NE=Lys-C;AC=MS:1001372	NE=Trypsin；AC=MS:1001314	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:4;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	64	
Sample 65	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_65.raw	65	NA	NE=Lys-C;AC=MS:1001373	NE=Trypsin；AC=MS:1001315	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:3;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	65	
Sample 66	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_66.raw	66	NA	NE=Lys-C;AC=MS:1001374	NE=Trypsin；AC=MS:1001316	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:2;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	66	
Sample 67	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_67.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_67.raw	67	NA	NE=Lys-C;AC=MS:1001375	NE=Trypsin；AC=MS:1001317	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	67	
Sample 68	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_68.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_68.raw	68	NA	NE=Lys-C;AC=MS:1001376	NE=Trypsin；AC=MS:1001318	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:0;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	68	
Sample 69	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_69.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_69.raw	69	NA	NE=Lys-C;AC=MS:1001377	NE=Trypsin；AC=MS:1001319	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	69	
Sample 70	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_70.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150115_QE3_UPLC9_DBJ_SA_Waters_70frac_no_concatenation_rep1_70.raw	70	NA	NE=Lys-C;AC=MS:1001378	NE=Trypsin；AC=MS:1001320	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	70	
Sample 71	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_1.raw	1	NA	NE=Lys-C;AC=MS:1001379	NE=Trypsin；AC=MS:1001321	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	71	
Sample 72	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_2.raw	2	NA	NE=Lys-C;AC=MS:1001380	NE=Trypsin；AC=MS:1001322	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:2;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	72	
Sample 73	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_3.raw	3	NA	NE=Lys-C;AC=MS:1001381	NE=Trypsin；AC=MS:1001323	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:3;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	73	
Sample 74	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_4.raw	4	NA	NE=Lys-C;AC=MS:1001382	NE=Trypsin；AC=MS:1001324	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:4;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	74	
Sample 75	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_5.raw	5	NA	NE=Lys-C;AC=MS:1001383	NE=Trypsin；AC=MS:1001325	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:5;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	75	
Sample 76	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_6.raw	6	NA	NE=Lys-C;AC=MS:1001384	NE=Trypsin；AC=MS:1001326	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:6;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	76	
Sample 77	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_7.raw	7	NA	NE=Lys-C;AC=MS:1001385	NE=Trypsin；AC=MS:1001327	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:7;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	77	
Sample 78	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_8.raw	8	NA	NE=Lys-C;AC=MS:1001386	NE=Trypsin；AC=MS:1001328	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:8;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	78	
Sample 79	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_9.raw	9	NA	NE=Lys-C;AC=MS:1001387	NE=Trypsin；AC=MS:1001329	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:9;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	79	
Sample 80	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_10.raw	10	NA	NE=Lys-C;AC=MS:1001388	NE=Trypsin；AC=MS:1001330	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:10;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	80	
Sample 81	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_11.raw	11	NA	NE=Lys-C;AC=MS:1001389	NE=Trypsin；AC=MS:1001331	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:11;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	81	
Sample 82	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_12.raw	12	NA	NE=Lys-C;AC=MS:1001390	NE=Trypsin；AC=MS:1001332	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:12;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	82	
Sample 83	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_13.raw	13	NA	NE=Lys-C;AC=MS:1001391	NE=Trypsin；AC=MS:1001333	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:13;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	83	
Sample 84	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_14.raw	14	NA	NE=Lys-C;AC=MS:1001392	NE=Trypsin；AC=MS:1001334	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:14;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	84	
Sample 85	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_15.raw	15	NA	NE=Lys-C;AC=MS:1001393	NE=Trypsin；AC=MS:1001335	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:15;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	85	
Sample 86	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_16.raw	16	NA	NE=Lys-C;AC=MS:1001394	NE=Trypsin；AC=MS:1001336	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:16;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	86	
Sample 87	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_17.raw	17	NA	NE=Lys-C;AC=MS:1001395	NE=Trypsin；AC=MS:1001337	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:17;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	87	
Sample 88	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_18.raw	18	NA	NE=Lys-C;AC=MS:1001396	NE=Trypsin；AC=MS:1001338	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:18;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	88	
Sample 89	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_19.raw	19	NA	NE=Lys-C;AC=MS:1001397	NE=Trypsin；AC=MS:1001339	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:19;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	89	
Sample 90	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_20.raw	20	NA	NE=Lys-C;AC=MS:1001398	NE=Trypsin；AC=MS:1001340	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:20;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	90	
Sample 91	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_21.raw	21	NA	NE=Lys-C;AC=MS:1001399	NE=Trypsin；AC=MS:1001341	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:21;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	91	
Sample 92	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_22.raw	22	NA	NE=Lys-C;AC=MS:1001400	NE=Trypsin；AC=MS:1001342	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:22;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	92	
Sample 93	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_23.raw	23	NA	NE=Lys-C;AC=MS:1001401	NE=Trypsin；AC=MS:1001343	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:23;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	93	
Sample 94	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_24.raw	24	NA	NE=Lys-C;AC=MS:1001402	NE=Trypsin；AC=MS:1001344	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:24;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	94	
Sample 95	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_25.raw	25	NA	NE=Lys-C;AC=MS:1001403	NE=Trypsin；AC=MS:1001345	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:25;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	95	
Sample 96	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_26.raw	26	NA	NE=Lys-C;AC=MS:1001404	NE=Trypsin；AC=MS:1001346	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:26;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	96	
Sample 97	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_27.raw	27	NA	NE=Lys-C;AC=MS:1001405	NE=Trypsin；AC=MS:1001347	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:27;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	97	
Sample 98	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_28.raw	28	NA	NE=Lys-C;AC=MS:1001406	NE=Trypsin；AC=MS:1001348	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:28;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	98	
Sample 99	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_29.raw	29	NA	NE=Lys-C;AC=MS:1001407	NE=Trypsin；AC=MS:1001349	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:29;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	99	
Sample 100	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_30.raw	30	NA	NE=Lys-C;AC=MS:1001408	NE=Trypsin；AC=MS:1001350	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:30;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	100	
Sample 101	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_31.raw	31	NA	NE=Lys-C;AC=MS:1001409	NE=Trypsin；AC=MS:1001351	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:31;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	101	
Sample 102	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_32.raw	32	NA	NE=Lys-C;AC=MS:1001410	NE=Trypsin；AC=MS:1001352	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:32;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	102	
Sample 103	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_33.raw	33	NA	NE=Lys-C;AC=MS:1001411	NE=Trypsin；AC=MS:1001353	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:33;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	103	
Sample 104	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_34.raw	34	NA	NE=Lys-C;AC=MS:1001412	NE=Trypsin；AC=MS:1001354	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:34;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	104	
Sample 105	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_35.raw	35	NA	NE=Lys-C;AC=MS:1001413	NE=Trypsin；AC=MS:1001355	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:35;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	105	
Sample 106	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_36.raw	36	NA	NE=Lys-C;AC=MS:1001414	NE=Trypsin；AC=MS:1001356	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:36;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	106	
Sample 107	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_37.raw	37	NA	NE=Lys-C;AC=MS:1001415	NE=Trypsin；AC=MS:1001357	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:37;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	107	
Sample 108	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_38.raw	38	NA	NE=Lys-C;AC=MS:1001416	NE=Trypsin；AC=MS:1001358	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:38;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	108	
Sample 109	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_39.raw	39	NA	NE=Lys-C;AC=MS:1001417	NE=Trypsin；AC=MS:1001359	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:39;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	109	
Sample 110	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_40.raw	40	NA	NE=Lys-C;AC=MS:1001418	NE=Trypsin；AC=MS:1001360	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:40;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	110	
Sample 111	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_41.raw	41	NA	NE=Lys-C;AC=MS:1001419	NE=Trypsin；AC=MS:1001361	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:41;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	111	
Sample 112	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_42.raw	42	NA	NE=Lys-C;AC=MS:1001420	NE=Trypsin；AC=MS:1001362	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:42;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	112	
Sample 113	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_43.raw	43	NA	NE=Lys-C;AC=MS:1001421	NE=Trypsin；AC=MS:1001363	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:43;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	113	
Sample 114	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_44.raw	44	NA	NE=Lys-C;AC=MS:1001422	NE=Trypsin；AC=MS:1001364	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:44;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	114	
Sample 115	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_45.raw	45	NA	NE=Lys-C;AC=MS:1001423	NE=Trypsin；AC=MS:1001365	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:45;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	115	
Sample 116	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150410_QE3_UPLC9_DBJ_SA_46fractions_Rep1_46.raw	46	NA	NE=Lys-C;AC=MS:1001424	NE=Trypsin；AC=MS:1001366	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Acetyl;AC=UNIMOD:46;TA=K;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=R;MT=Variable	NM=Methyl;AC=UNIMOD:34;TA=K;MT=Variable	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	116	
Sample 117	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_1.raw	1	NA	NE=Lys-C;AC=MS:1001425	NE=Trypsin；AC=MS:1001367	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	117	
Sample 118	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_2.raw	2	NA	NE=Lys-C;AC=MS:1001426	NE=Trypsin；AC=MS:1001368	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	118	
Sample 119	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_3.raw	3	NA	NE=Lys-C;AC=MS:1001427	NE=Trypsin；AC=MS:1001369	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	119	
Sample 120	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_4.raw	4	NA	NE=Lys-C;AC=MS:1001428	NE=Trypsin；AC=MS:1001370	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	120	
Sample 121	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_5.raw	5	NA	NE=Lys-C;AC=MS:1001429	NE=Trypsin；AC=MS:1001371	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	121	
Sample 122	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_6.raw	6	NA	NE=Lys-C;AC=MS:1001430	NE=Trypsin；AC=MS:1001372	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	122	
Sample 123	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_7.raw	7	NA	NE=Lys-C;AC=MS:1001431	NE=Trypsin；AC=MS:1001373	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	123	
Sample 124	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_8.raw	8	NA	NE=Lys-C;AC=MS:1001432	NE=Trypsin；AC=MS:1001374	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	124	
Sample 125	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_9.raw	9	NA	NE=Lys-C;AC=MS:1001433	NE=Trypsin；AC=MS:1001375	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	125	
Sample 126	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_10.raw	10	NA	NE=Lys-C;AC=MS:1001434	NE=Trypsin；AC=MS:1001376	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	126	
Sample 127	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_11.raw	11	NA	NE=Lys-C;AC=MS:1001435	NE=Trypsin；AC=MS:1001377	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	127	
Sample 128	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH10_12.raw	12	NA	NE=Lys-C;AC=MS:1001436	NE=Trypsin；AC=MS:1001378	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	128	
Sample 129	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_1.raw	1	NA	NE=Lys-C;AC=MS:1001437	NE=Trypsin；AC=MS:1001379	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	129	
Sample 130	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_2.raw	2	NA	NE=Lys-C;AC=MS:1001438	NE=Trypsin；AC=MS:1001380	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	130	
Sample 131	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_3.raw	3	NA	NE=Lys-C;AC=MS:1001439	NE=Trypsin；AC=MS:1001381	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	131	
Sample 132	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_4.raw	4	NA	NE=Lys-C;AC=MS:1001440	NE=Trypsin；AC=MS:1001382	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	132	
Sample 133	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_5.raw	5	NA	NE=Lys-C;AC=MS:1001441	NE=Trypsin；AC=MS:1001383	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	133	
Sample 134	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_6.raw	6	NA	NE=Lys-C;AC=MS:1001442	NE=Trypsin；AC=MS:1001384	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	134	
Sample 135	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_7.raw	7	NA	NE=Lys-C;AC=MS:1001443	NE=Trypsin；AC=MS:1001385	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	135	
Sample 136	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_8.raw	8	NA	NE=Lys-C;AC=MS:1001444	NE=Trypsin；AC=MS:1001386	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	136	
Sample 137	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_9.raw	9	NA	NE=Lys-C;AC=MS:1001445	NE=Trypsin；AC=MS:1001387	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	137	
Sample 138	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_10.raw	10	NA	NE=Lys-C;AC=MS:1001446	NE=Trypsin；AC=MS:1001388	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	138	
Sample 139	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_11.raw	11	NA	NE=Lys-C;AC=MS:1001447	NE=Trypsin；AC=MS:1001389	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	139	
Sample 140	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150517_QE5_UPLC8_DBJ_SA_Hela_3mg_phospho_pH8_12.raw	12	NA	NE=Lys-C;AC=MS:1001448	NE=Trypsin；AC=MS:1001390	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NM=Phospho;TA=S;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=T;MT=Variable;AC=UNIMOD:21	NM=Phospho;TA=Y;MT=Variable;AC=UNIMOD:21	AC=MS:1002038;NM=label free sample	NA	NA	140	
Sample 141	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_1.raw	1	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	141	
Sample 142	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_2.raw	2	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	142	
Sample 143	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_3.raw	3	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	143	
Sample 144	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_4.raw	4	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	144	
Sample 145	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_5.raw	5	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	145	
Sample 146	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_6.raw	6	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	146	
Sample 147	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_7.raw	7	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	147	
Sample 148	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_8.raw	8	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	148	
Sample 149	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_9.raw	9	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	149	
Sample 150	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_10.raw	10	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	150	
Sample 151	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_11.raw	11	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	151	
Sample 152	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_12.raw	12	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	152	
Sample 153	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_13.raw	13	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	153	
Sample 154	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_14.raw	14	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	154	
Sample 155	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_15.raw	15	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	155	
Sample 156	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_16.raw	16	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	156	
Sample 157	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_17.raw	17	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	157	
Sample 158	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_18.raw	18	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	158	
Sample 159	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_19.raw	19	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	159	
Sample 160	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_20.raw	20	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	160	
Sample 161	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_21_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_21_2.raw	21	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	161	
Sample 162	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_22_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_22_2.raw	22	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	162	
Sample 163	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_23_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_23_2.raw	23	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	163	
Sample 164	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_24.raw	24	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	164	
Sample 165	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_25.raw	25	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	165	
Sample 166	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_26.raw	26	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	166	
Sample 167	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_27.raw	27	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	167	
Sample 168	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_28.raw	28	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	168	
Sample 169	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_29.raw	29	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	169	
Sample 170	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_30.raw	30	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	170	
Sample 171	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_31.raw	31	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	171	
Sample 172	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_32.raw	32	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	172	
Sample 173	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_33.raw	33	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	173	
Sample 174	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_34.raw	34	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	174	
Sample 175	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_35.raw	35	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	175	
Sample 176	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_36.raw	36	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	176	
Sample 177	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_37.raw	37	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	177	
Sample 178	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_38.raw	38	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	178	
Sample 179	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Chymotrypsin_39.raw	39	NA	NE=Chymotrypsin;AC=MS:1001306	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	179	
Sample 180	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_1.raw	1	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	180	
Sample 181	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_2.raw	2	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	181	
Sample 182	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_3.raw	3	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	182	
Sample 183	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_4.raw	4	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	183	
Sample 184	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_5.raw	5	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	184	
Sample 185	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_6.raw	6	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	185	
Sample 186	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_7.raw	7	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	186	
Sample 187	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_8.raw	8	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	187	
Sample 188	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_9.raw	9	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	188	
Sample 189	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_10.raw	10	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	189	
Sample 190	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_11.raw	11	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	190	
Sample 191	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_12.raw	12	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	191	
Sample 192	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_13.raw	13	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	192	
Sample 193	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_14.raw	14	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	193	
Sample 194	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_15.raw	15	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	194	
Sample 195	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_16.raw	16	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	195	
Sample 196	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_17.raw	17	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	196	
Sample 197	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_18.raw	18	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	197	
Sample 198	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_19.raw	19	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	198	
Sample 199	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_20.raw	20	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	199	
Sample 200	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_21.raw	21	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	200	
Sample 201	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_22.raw	22	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	201	
Sample 202	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_23.raw	23	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	202	
Sample 203	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_24.raw	24	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	203	
Sample 204	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_25.raw	25	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	204	
Sample 205	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_26.raw	26	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	205	
Sample 206	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_27.raw	27	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	206	
Sample 207	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_28.raw	28	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	207	
Sample 208	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_29.raw	29	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	208	
Sample 209	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_30.raw	30	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	209	
Sample 210	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_31.raw	31	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	210	
Sample 211	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_32.raw	32	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	211	
Sample 212	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_33.raw	33	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	212	
Sample 213	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_34.raw	34	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	213	
Sample 214	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_35.raw	35	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	214	
Sample 215	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_36.raw	36	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	215	
Sample 216	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_37.raw	37	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	216	
Sample 217	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_38.raw	38	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	217	
Sample 218	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_GluC_39.raw	39	NA	NE=Glu-C;AC=MS:1001917	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	218	
Sample 219	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_1.raw	1	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	219	
Sample 220	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_2.raw	2	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	220	
Sample 221	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_3.raw	3	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	221	
Sample 222	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_4.raw	4	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	222	
Sample 223	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_5.raw	5	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	223	
Sample 224	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_6.raw	6	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	224	
Sample 225	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_7.raw	7	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	225	
Sample 226	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_8.raw	8	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	226	
Sample 227	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_9.raw	9	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	227	
Sample 228	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_10.raw	10	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	228	
Sample 229	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_11.raw	11	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	229	
Sample 230	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_12.raw	12	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	230	
Sample 231	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_13.raw	13	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	231	
Sample 232	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_14.raw	14	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	232	
Sample 233	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_15.raw	15	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	233	
Sample 234	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_16.raw	16	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	234	
Sample 235	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_17.raw	17	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	235	
Sample 236	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_18.raw	18	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	236	
Sample 237	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_19.raw	19	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	237	
Sample 238	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_20.raw	20	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	238	
Sample 239	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_21.raw	21	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	239	
Sample 240	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_22.raw	22	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	240	
Sample 241	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_23.raw	23	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	241	
Sample 242	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_24.raw	24	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	242	
Sample 243	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_25.raw	25	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	243	
Sample 244	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_26.raw	26	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	244	
Sample 245	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_27.raw	27	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	245	
Sample 246	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_28.raw	28	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	246	
Sample 247	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_29.raw	29	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	247	
Sample 248	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_30.raw	30	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	248	
Sample 249	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_31.raw	31	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	249	
Sample 250	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_32.raw	32	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	250	
Sample 251	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_33.raw	33	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	251	
Sample 252	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_34.raw	34	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	252	
Sample 253	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_35.raw	35	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	253	
Sample 254	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_36.raw	36	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	254	
Sample 255	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_37.raw	37	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	255	
Sample 256	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_38.raw	38	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	256	
Sample 257	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_39.raw	39	NA	NE=Lys-C;AC=MS:1001309	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	257	
Sample 258	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_1.raw	1	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	258	
Sample 259	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_2.raw	2	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	259	
Sample 260	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_3.raw	3	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	260	
Sample 261	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_4.raw	4	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	261	
Sample 262	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_5.raw	5	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	262	
Sample 263	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_6.raw	6	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	263	
Sample 264	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_7.raw	7	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	264	
Sample 265	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_8.raw	8	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	265	
Sample 266	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_9.raw	9	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	266	
Sample 267	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_10.raw	10	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	267	
Sample 268	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_11.raw	11	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	268	
Sample 269	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_12.raw	12	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	269	
Sample 270	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_13.raw	13	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	270	
Sample 271	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_14.raw	14	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	271	
Sample 272	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_15.raw	15	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	272	
Sample 273	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_16.raw	16	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	273	
Sample 274	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_17.raw	17	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	274	
Sample 275	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_18.raw	18	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	275	
Sample 276	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_19.raw	19	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	276	
Sample 277	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_20.raw	20	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	277	
Sample 278	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_21.raw	21	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	278	
Sample 279	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_22.raw	22	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	279	
Sample 280	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_23.raw	23	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	280	
Sample 281	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_24.raw	24	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	281	
Sample 282	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_25.raw	25	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	282	
Sample 283	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_26.raw	26	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	283	
Sample 284	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_27.raw	27	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	284	
Sample 285	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_28.raw	28	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	285	
Sample 286	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_29.raw	29	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	286	
Sample 287	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_30.raw	30	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	287	
Sample 288	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_31.raw	31	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	288	
Sample 289	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_32.raw	32	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	289	
Sample 290	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_33.raw	33	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	290	
Sample 291	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_34.raw	34	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	291	
Sample 292	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_35.raw	35	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	292	
Sample 293	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_36.raw	36	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	293	
Sample 294	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_37.raw	37	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	294	
Sample 295	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_38.raw	38	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	295	
Sample 296	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_SA_Hela_39frac_Trypsin_39.raw	39	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	296	
Sample 297	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_39_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_Trypsin_39_2.raw	39_2	NA	NE=Trypsin；AC=MS:1001251	NA	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	297	
Sample 298	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_1.raw	1	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	298	
Sample 299	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_2.raw	2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	299	
Sample 300	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_3.raw	3	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	300	
Sample 301	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_4.raw	4	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	301	
Sample 302	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_5.raw	5	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	302	
Sample 303	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_6.raw	6	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	303	
Sample 304	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_7.raw	7	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	304	
Sample 305	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_8.raw	8	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	305	
Sample 306	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_9.raw	9	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	306	
Sample 307	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_10.raw	10	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	307	
Sample 308	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_11.raw	11	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	308	
Sample 309	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_12.raw	12	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	309	
Sample 310	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_13.raw	13	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	310	
Sample 311	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_14.raw	14	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	311	
Sample 312	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_15.raw	15	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	312	
Sample 313	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_16.raw	16	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	313	
Sample 314	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_17.raw	17	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	314	
Sample 315	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_18.raw	18	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	315	
Sample 316	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_19.raw	19	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	316	
Sample 317	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_20.raw	20	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	317	
Sample 318	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_21.raw	21	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	318	
Sample 319	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_22.raw	22	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	319	
Sample 320	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_23.raw	23	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	320	
Sample 321	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_24.raw	24	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	321	
Sample 322	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_25.raw	25	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	322	
Sample 323	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_26.raw	26	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	323	
Sample 324	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_27.raw	27	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	324	
Sample 325	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_28.raw	28	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	325	
Sample 326	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_29.raw	29	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	326	
Sample 327	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_30.raw	30	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	327	
Sample 328	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_31.raw	31	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	328	
Sample 329	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_32.raw	32	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	329	
Sample 330	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_33.raw	33	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	330	
Sample 331	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_34.raw	34	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	331	
Sample 332	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_35.raw	35	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	332	
Sample 333	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_36.raw	36	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	333	
Sample 334	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_37.raw	37	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	334	
Sample 335	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_38.raw	38	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	335	
Sample 336	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_39.raw	39	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	336	
Sample 337	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_40.raw	40	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	337	
Sample 338	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_41.raw	41	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	338	
Sample 339	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_42.raw	42	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	339	
Sample 340	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_43.raw	43	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	340	
Sample 341	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_44.raw	44	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	341	
Sample 342	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_45.raw	45	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	342	
Sample 343	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_46.raw	46	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	343	
Sample 344	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_47.raw	47	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	344	
Sample 345	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_48.raw	48	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	345	
Sample 346	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_49.raw	49	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	346	
Sample 347	Homo sapiens	NA	HeLa	NA	NA	Female	epithelial cervix carcinoma	NA	NA	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_50.raw	50	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	347	
Sample 348	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_1.raw	1	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	348	
Sample 349	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_2.raw	2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	349	
Sample 350	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_3.raw	3	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	350	
Sample 351	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_4.raw	4	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	351	
Sample 352	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_5.raw	5	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	352	
Sample 353	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_6.raw	6	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	353	
Sample 354	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_7.raw	7	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	354	
Sample 355	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_8.raw	8	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	355	
Sample 356	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_9.raw	9	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	356	
Sample 357	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_10.raw	10	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	357	
Sample 358	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_11.raw	11	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	358	
Sample 359	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_12.raw	12	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	359	
Sample 360	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_13.raw	13	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	360	
Sample 361	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_14.raw	14	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	361	
Sample 362	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_15.raw	15	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	362	
Sample 363	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_16.raw	16	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	363	
Sample 364	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_17.raw	17	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	364	
Sample 365	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_18.raw	18	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	365	
Sample 366	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_19.raw	19	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	366	
Sample 367	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_19_151014124632.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_19_151014124632.raw	19_151014124632	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	367	
Sample 368	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_20.raw	20	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	368	
Sample 369	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_21.raw	21	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	369	
Sample 370	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_22.raw	22	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	370	
Sample 371	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_23.raw	23	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	371	
Sample 372	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_24.raw	24	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	372	
Sample 373	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_25.raw	25	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	373	
Sample 374	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_26.raw	26	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	374	
Sample 375	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_27.raw	27	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	375	
Sample 376	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_28.raw	28	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	376	
Sample 377	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_29.raw	29	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	377	
Sample 378	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_30.raw	30	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	378	
Sample 379	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_31.raw	31	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	379	
Sample 380	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_32.raw	32	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	380	
Sample 381	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_32_151014133246.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_32_151014133246.raw	32_151014133246	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	381	
Sample 382	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_33.raw	33	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	382	
Sample 383	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_34.raw	34	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	383	
Sample 384	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_34_151014141957.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_34_151014141957.raw	34_151014141957	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	384	
Sample 385	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_34_151014191631.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_34_151014191631.raw	34_151014191631	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	385	
Sample 386	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_35.raw	35	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	386	
Sample 387	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_35_151014200242.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_35_151014200242.raw	35_151014200242	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	387	
Sample 388	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_36.raw	36	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	388	
Sample 389	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_37.raw	37	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	389	
Sample 390	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_37_151014204857.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_37_151014204857.raw	37_151014204857	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	390	
Sample 391	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_38.raw	38	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	391	
Sample 392	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_38_151014213514.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_38_151014213514.raw	38_151014213514	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	392	
Sample 393	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_39.raw	39	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	393	
Sample 394	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_40.raw	40	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	394	
Sample 395	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_41.raw	41	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	395	
Sample 396	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_42.raw	42	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	396	
Sample 397	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_42_151014222133.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_42_151014222133.raw	42_151014222133	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	397	
Sample 398	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_43.raw	43	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	398	
Sample 399	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_44.raw	44	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	399	
Sample 400	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_45.raw	45	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	400	
Sample 401	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_46.raw	46	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	401	
Sample 402	Homo sapiens	Colon	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_46_151014230754.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_COLON_human_46frac_46_151014230754.raw	46_151014230754	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	402	
Sample 403	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_1.raw	1	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	403	
Sample 404	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_2.raw	2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	404	
Sample 405	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_3.raw	3	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	405	
Sample 406	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_4.raw	4	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	406	
Sample 407	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_5.raw	5	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	407	
Sample 408	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_6.raw	6	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	408	
Sample 409	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_7.raw	7	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	409	
Sample 410	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_8.raw	8	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	410	
Sample 411	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_9.raw	9	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	411	
Sample 412	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_10.raw	10	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	412	
Sample 413	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_11.raw	11	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	413	
Sample 414	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_11_151010165746.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_11_151010165746.raw	11_151010165746	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	414	
Sample 415	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_12.raw	12	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	415	
Sample 416	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_12_151010174730.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_12_151010174730.raw	12_151010174730	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	416	
Sample 417	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_13.raw	13	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	417	
Sample 418	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_13_151011001441.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_13_151011001441.raw	13_151011001441	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	418	
Sample 419	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_13_151012112639.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_13_151012112639.raw	13_151012112639	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	419	
Sample 420	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_14.raw	14	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	420	
Sample 421	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_14_151011091039.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_14_151011091039.raw	14_151011091039	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	421	
Sample 422	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_14_151012121230.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_14_151012121230.raw	14_151012121230	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	422	
Sample 423	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_15.raw	15	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	423	
Sample 424	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_15_151012125825.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_15_151012125825.raw	15_151012125825	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	424	
Sample 425	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_16.raw	16	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	425	
Sample 426	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_16_151012134422.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_16_151012134422.raw	16_151012134422	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	426	
Sample 427	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_17.raw	17	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	427	
Sample 428	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_17_151012143021.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_17_151012143021.raw	17_151012143021	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	428	
Sample 429	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_18.raw	18	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	429	
Sample 430	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_18_151012151618.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_18_151012151618.raw	18_151012151618	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	430	
Sample 431	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_19.raw	19	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	431	
Sample 432	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_20.raw	20	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	432	
Sample 433	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_21.raw	21	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	433	
Sample 434	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_22.raw	22	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	434	
Sample 435	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_23.raw	23	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	435	
Sample 436	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_24.raw	24	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	436	
Sample 437	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_25.raw	25	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	437	
Sample 438	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_26.raw	26	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	438	
Sample 439	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_27.raw	27	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	439	
Sample 440	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_28.raw	28	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	440	
Sample 441	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_29.raw	29	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	441	
Sample 442	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_30.raw	30	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	442	
Sample 443	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_31.raw	31	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	443	
Sample 444	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_32.raw	32	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	444	
Sample 445	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_33.raw	33	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	445	
Sample 446	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_33_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_33_2.raw	33_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	446	
Sample 447	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_34.raw	34	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	447	
Sample 448	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_34_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_34_2.raw	34_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	448	
Sample 449	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_35.raw	35	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	449	
Sample 450	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_36.raw	36	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	450	
Sample 451	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_37.raw	37	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	451	
Sample 452	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_38.raw	38	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	452	
Sample 453	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_39.raw	39	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	453	
Sample 454	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_40.raw	40	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	454	
Sample 455	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_41.raw	41	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	455	
Sample 456	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_42.raw	42	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	456	
Sample 457	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_43.raw	43	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	457	
Sample 458	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_44.raw	44	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	458	
Sample 459	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_45.raw	45	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	459	
Sample 460	Homo sapiens	Liver	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_LIVER_human_46frac_46.raw	46	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	460	
Sample 461	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_1.raw	1	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	461	
Sample 462	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_2.raw	2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	462	
Sample 463	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_3.raw	3	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	463	
Sample 464	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_4.raw	4	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	464	
Sample 465	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_5.raw	5	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	465	
Sample 466	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_6.raw	6	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	466	
Sample 467	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_7.raw	7	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	467	
Sample 468	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_8.raw	8	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	468	
Sample 469	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_9.raw	9	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	469	
Sample 470	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_10.raw	10	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	470	
Sample 471	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_11.raw	11	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	471	
Sample 472	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_11_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_11_2.raw	11_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	472	
Sample 473	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_12.raw	12	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	473	
Sample 474	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_12_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_12_2.raw	12_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	474	
Sample 475	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_13.raw	13	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	475	
Sample 476	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_13_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_13_2.raw	13_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	476	
Sample 477	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_14.raw	14	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	477	
Sample 478	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_14_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_14_2.raw	14_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	478	
Sample 479	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_15.raw	15	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	479	
Sample 480	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_15_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_15_2.raw	15_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	480	
Sample 481	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_16.raw	16	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	481	
Sample 482	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_17.raw	17	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	482	
Sample 483	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_18.raw	18	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	483	
Sample 484	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_18_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_18_2.raw	19	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	484	
Sample 485	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_19.raw	20	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	485	
Sample 486	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_20.raw	20	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	486	
Sample 487	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_21.raw	21	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	487	
Sample 488	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_22.raw	22	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	488	
Sample 489	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_23.raw	23	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	489	
Sample 490	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_24.raw	24	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	490	
Sample 491	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_25.raw	25	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	491	
Sample 492	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_26.raw	26	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	492	
Sample 493	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_27.raw	27	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	493	
Sample 494	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_27_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_27_2.raw	27_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	494	
Sample 495	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_28.raw	28	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	495	
Sample 496	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_28_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_28_2.raw	28_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	496	
Sample 497	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_29.raw	29	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	497	
Sample 498	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_29_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_29_2.raw	29_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	498	
Sample 499	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_30.raw	30	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	499	
Sample 500	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_30_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_30_2.raw	30_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	500	
Sample 501	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_31.raw	31	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	501	
Sample 502	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_32.raw	32	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	502	
Sample 503	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_33.raw	33	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	503	
Sample 504	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_33_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_33_2.raw	33_2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	504	
Sample 505	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_34.raw	34	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	505	
Sample 506	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_35.raw	35	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	506	
Sample 507	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_36.raw	36	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	507	
Sample 508	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_37.raw	37	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	508	
Sample 509	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_38.raw	38	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	509	
Sample 510	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_39.raw	39	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	510	
Sample 511	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_40.raw	40	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	511	
Sample 512	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_41.raw	41	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	512	
Sample 513	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_42.raw	42	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	513	
Sample 514	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_43.raw	43	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	514	
Sample 515	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_44.raw	44	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	515	
Sample 516	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_45.raw	45	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	516	
Sample 517	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt2_human_46frac_46.raw	46	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	517	
Sample 518	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_1.raw	1	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	518	
Sample 519	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_2.raw	2	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	519	
Sample 520	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_3.raw	3	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	520	
Sample 521	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_4.raw	4	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	521	
Sample 522	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_5.raw	5	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	522	
Sample 523	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_6.raw	6	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	523	
Sample 524	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_7.raw	7	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	524	
Sample 525	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_8.raw	8	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	525	
Sample 526	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_9.raw	9	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	526	
Sample 527	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_10.raw	10	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	527	
Sample 528	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_11.raw	11	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	528	
Sample 529	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_12.raw	12	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	529	
Sample 530	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_13.raw	13	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	530	
Sample 531	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_14.raw	14	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	531	
Sample 532	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_15.raw	15	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	532	
Sample 533	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_16.raw	16	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	533	
Sample 534	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_17.raw	17	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	534	
Sample 535	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_18.raw	18	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	535	
Sample 536	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_19.raw	19	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	536	
Sample 537	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_20.raw	20	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	537	
Sample 538	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_21.raw	21	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	538	
Sample 539	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_22.raw	22	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	539	
Sample 540	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_23.raw	23	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	540	
Sample 541	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_24.raw	24	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	541	
Sample 542	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_25.raw	25	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	542	
Sample 543	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_26.raw	26	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	543	
Sample 544	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_27.raw	27	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	544	
Sample 545	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_28.raw	28	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	545	
Sample 546	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_29.raw	29	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	546	
Sample 547	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_30.raw	30	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	547	
Sample 548	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_31.raw	31	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	548	
Sample 549	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_32.raw	32	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	549	
Sample 550	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_33.raw	33	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	550	
Sample 551	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_34.raw	34	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	551	
Sample 552	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_35.raw	35	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	552	
Sample 553	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_36.raw	36	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	553	
Sample 554	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_37.raw	37	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	554	
Sample 555	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_38.raw	38	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	555	
Sample 556	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_39.raw	39	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	556	
Sample 557	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_40.raw	40	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	557	
Sample 558	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_41.raw	41	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	558	
Sample 559	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_42.raw	42	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	559	
Sample 560	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_43.raw	43	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	560	
Sample 561	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_44.raw	44	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	561	
Sample 562	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_45.raw	45	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	562	
Sample 563	Homo sapiens	Prostate	NA	NA	NA	NA	NA	NA	NA	20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151008_QE5_UPLC10_DBJ_SA_PROSTATE_Pt3_human_46frac_46.raw	46	NA	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	563	
Sample 564	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_1.raw	1	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	564	
Sample 565	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_2.raw	2	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	565	
Sample 566	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_3.raw	3	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	566	
Sample 567	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_4.raw	4	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	567	
Sample 568	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_5.raw	5	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	568	
Sample 569	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_6.raw	6	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	569	
Sample 570	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_7.raw	7	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	570	
Sample 571	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_8.raw	8	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	571	
Sample 572	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_9.raw	9	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	572	
Sample 573	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_10.raw	10	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	573	
Sample 574	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_11.raw	11	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	574	
Sample 575	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_12.raw	12	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	575	
Sample 576	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_13.raw	13	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	576	
Sample 577	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_14.raw	14	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	577	
Sample 578	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_15.raw	15	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	578	
Sample 579	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_16.raw	16	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	579	
Sample 580	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_17.raw	17	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	580	
Sample 581	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_18.raw	18	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	581	
Sample 582	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_19.raw	19	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	582	
Sample 583	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_20.raw	20	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	583	
Sample 584	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_21.raw	21	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	584	
Sample 585	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_22.raw	22	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	585	
Sample 586	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_23.raw	23	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	586	
Sample 587	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_24.raw	24	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	587	
Sample 588	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_25.raw	25	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	588	
Sample 589	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_26.raw	26	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	589	
Sample 590	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_27.raw	27	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	590	
Sample 591	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_28.raw	28	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	591	
Sample 592	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_29.raw	29	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	592	
Sample 593	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_30.raw	30	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	593	
Sample 594	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_31.raw	31	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	594	
Sample 595	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_32.raw	32	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	595	
Sample 596	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_33.raw	33	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	596	
Sample 597	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_34.raw	34	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	597	
Sample 598	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_35.raw	35	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	598	
Sample 599	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_36.raw	36	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	599	
Sample 600	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_37.raw	37	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	600	
Sample 601	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_38.raw	38	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	601	
Sample 602	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_39.raw	39	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	602	
Sample 603	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_40.raw	40	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	603	
Sample 604	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_41.raw	41	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	604	
Sample 605	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_42.raw	42	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	605	
Sample 606	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_43.raw	43	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	606	
Sample 607	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_44.raw	44	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	607	
Sample 608	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_45.raw	45	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	608	
Sample 609	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_A549_Rep2_46frac_46.raw	46	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	609	
Sample 610	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_1.raw	1	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	610	
Sample 611	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_2.raw	2	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	611	
Sample 612	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_3.raw	3	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	612	
Sample 613	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_4.raw	4	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	613	
Sample 614	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_5.raw	5	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	614	
Sample 615	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_6.raw	6	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	615	
Sample 616	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_7.raw	7	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	616	
Sample 617	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_8.raw	8	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	617	
Sample 618	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_9.raw	9	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	618	
Sample 619	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_10.raw	10	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	619	
Sample 620	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_11.raw	11	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	620	
Sample 621	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_12.raw	12	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	621	
Sample 622	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_13.raw	13	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	622	
Sample 623	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_14.raw	14	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	623	
Sample 624	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_15.raw	15	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	624	
Sample 625	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_16.raw	16	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	625	
Sample 626	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_17.raw	17	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	626	
Sample 627	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_18.raw	18	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	627	
Sample 628	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_19.raw	19	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	628	
Sample 629	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_20.raw	20	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	629	
Sample 630	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_21.raw	21	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	630	
Sample 631	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_22.raw	22	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	631	
Sample 632	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_23.raw	23	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	632	
Sample 633	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_24.raw	24	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	633	
Sample 634	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_25.raw	25	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	634	
Sample 635	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_26.raw	26	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	635	
Sample 636	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_27.raw	27	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	636	
Sample 637	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_28.raw	28	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	637	
Sample 638	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_29.raw	29	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	638	
Sample 639	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_30.raw	30	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	639	
Sample 640	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_31.raw	31	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	640	
Sample 641	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_32.raw	32	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	641	
Sample 642	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_33.raw	33	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	642	
Sample 643	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_34.raw	34	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	643	
Sample 644	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_35.raw	35	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	644	
Sample 645	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_36.raw	36	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	645	
Sample 646	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_37.raw	37	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	646	
Sample 647	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_38.raw	38	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	647	
Sample 648	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_39.raw	39	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	648	
Sample 649	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_40.raw	40	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	649	
Sample 650	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_41.raw	41	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	650	
Sample 651	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_42.raw	42	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	651	
Sample 652	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_43.raw	43	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	652	
Sample 653	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_44.raw	44	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	653	
Sample 654	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_45.raw	45	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	654	
Sample 655	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_293_REP2_46frac_46.raw	46	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	655	
Sample 656	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_1.raw	1	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	656	
Sample 657	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_2.raw	2	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	657	
Sample 658	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_3.raw	3	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	658	
Sample 659	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_4.raw	4	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	659	
Sample 660	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_5.raw	5	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	660	
Sample 661	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_6.raw	6	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	661	
Sample 662	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_7.raw	7	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	662	
Sample 663	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_8.raw	8	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	663	
Sample 664	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_9.raw	9	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	664	
Sample 665	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_10.raw	10	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	665	
Sample 666	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_11.raw	11	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	666	
Sample 667	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_12.raw	12	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	667	
Sample 668	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_13.raw	13	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	668	
Sample 669	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_14.raw	14	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	669	
Sample 670	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_15.raw	15	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	670	
Sample 671	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_16.raw	16	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	671	
Sample 672	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_17.raw	17	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	672	
Sample 673	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_18.raw	18	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	673	
Sample 674	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_19.raw	19	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	674	
Sample 675	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_20.raw	20	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	675	
Sample 676	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_21.raw	21	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	676	
Sample 677	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_22.raw	22	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	677	
Sample 678	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_23.raw	23	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	678	
Sample 679	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_24.raw	24	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	679	
Sample 680	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_25.raw	25	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	680	
Sample 681	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_26.raw	26	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	681	
Sample 682	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_27.raw	27	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	682	
Sample 683	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_28.raw	28	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	683	
Sample 684	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_29.raw	29	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	684	
Sample 685	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_30.raw	30	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	685	
Sample 686	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_31.raw	31	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	686	
Sample 687	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_32.raw	32	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	687	
Sample 688	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_33.raw	33	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	688	
Sample 689	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_34.raw	34	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	689	
Sample 690	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_35.raw	35	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	690	
Sample 691	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_36.raw	36	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	691	
Sample 692	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_37.raw	37	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	692	
Sample 693	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_38.raw	38	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	693	
Sample 694	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_39.raw	39	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	694	
Sample 695	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_40.raw	40	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	695	
Sample 696	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_41.raw	41	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	696	
Sample 697	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_42.raw	42	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	697	
Sample 698	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_43.raw	43	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	698	
Sample 699	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_44.raw	44	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	699	
Sample 700	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_45.raw	45	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	700	
Sample 701	Homo sapiens	NA	HTC116	NA	NA	NA	colon cancer	NA	NA	20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151020_QE3_UPLC8_DBJ_SA_HCT116_Rep2_46frac_46.raw	46	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	701	
Sample 702	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_1.raw	1	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	702	
Sample 703	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_2.raw	2	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	703	
Sample 704	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_3.raw	3	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	704	
Sample 705	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_4.raw	4	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	705	
Sample 706	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_5.raw	5	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	706	
Sample 707	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_6.raw	6	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	707	
Sample 708	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_7.raw	7	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	708	
Sample 709	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_8.raw	8	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	709	
Sample 710	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_9.raw	9	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	710	
Sample 711	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_10.raw	10	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	711	
Sample 712	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_11.raw	11	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	712	
Sample 713	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_12.raw	12	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	713	
Sample 714	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_13.raw	13	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	714	
Sample 715	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_14.raw	14	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	715	
Sample 716	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_15.raw	15	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	716	
Sample 717	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_16.raw	16	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	717	
Sample 718	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_17.raw	17	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	718	
Sample 719	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_18.raw	18	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	719	
Sample 720	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_19.raw	19	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	720	
Sample 721	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_20.raw	20	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	721	
Sample 722	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_21.raw	21	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	722	
Sample 723	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_22.raw	22	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	723	
Sample 724	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_23.raw	23	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	724	
Sample 725	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_24.raw	24	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	725	
Sample 726	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_25.raw	25	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	726	
Sample 727	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_26.raw	26	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	727	
Sample 728	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_27.raw	27	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	728	
Sample 729	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_28.raw	28	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	729	
Sample 730	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_29.raw	29	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	730	
Sample 731	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_30.raw	30	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	731	
Sample 732	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_31.raw	31	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	732	
Sample 733	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_32.raw	32	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	733	
Sample 734	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_33.raw	33	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	734	
Sample 735	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_34.raw	34	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	735	
Sample 736	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_35.raw	35	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	736	
Sample 737	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_36.raw	36	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	737	
Sample 738	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_37.raw	37	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	738	
Sample 739	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_38.raw	38	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	739	
Sample 740	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_39.raw	39	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	740	
Sample 741	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_40.raw	40	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	741	
Sample 742	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_41.raw	41	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	742	
Sample 743	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_42.raw	42	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	743	
Sample 744	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_43.raw	43	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	744	
Sample 745	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_44.raw	44	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	745	
Sample 746	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_45.raw	45	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	746	
Sample 747	Homo sapiens	NA	SH-SY5Y	NA	NA	Female	neuroblastoma	NA	NA	20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151022_QE5_UPLC10_DBJ_SA_SH-SY5Y_REP2_46frac_46.raw	46	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	747	
Sample 748	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_1.raw	1	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	748	
Sample 749	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_2.raw	2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	749	
Sample 750	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_3.raw	3	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	750	
Sample 751	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_4.raw	4	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	751	
Sample 752	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_5_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_5_2.raw	5_2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	752	
Sample 753	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_6_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_6_2.raw	6_2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	753	
Sample 754	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_7_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_7_2.raw	7_2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	754	
Sample 755	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_8_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_8_2.raw	8_2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	755	
Sample 756	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_9_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_9_2.raw	9_2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	756	
Sample 757	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_10.raw	10	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	757	
Sample 758	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_11.raw	11	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	758	
Sample 759	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_12.raw	12	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	759	
Sample 760	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_13.raw	13	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	760	
Sample 761	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_14.raw	14	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	761	
Sample 762	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_15.raw	15	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	762	
Sample 763	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_16.raw	16	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	763	
Sample 764	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_17.raw	17	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	764	
Sample 765	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_18.raw	18	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	765	
Sample 766	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_19.raw	19	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	766	
Sample 767	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_20.raw	20	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	767	
Sample 768	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_21.raw	21	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	768	
Sample 769	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_22.raw	22	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	769	
Sample 770	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_23.raw	23	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	770	
Sample 771	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_24.raw	24	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	771	
Sample 772	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_25.raw	25	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	772	
Sample 773	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_26.raw	26	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	773	
Sample 774	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_27.raw	27	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	774	
Sample 775	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_28.raw	28	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	775	
Sample 776	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_29.raw	29	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	776	
Sample 777	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_30.raw	30	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	777	
Sample 778	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_31.raw	31	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	778	
Sample 779	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_32.raw	32	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	779	
Sample 780	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_33.raw	33	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	780	
Sample 781	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_34.raw	34	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	781	
Sample 782	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_35.raw	35	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	782	
Sample 783	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_36.raw	36	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	783	
Sample 784	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_37.raw	37	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	784	
Sample 785	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_38.raw	38	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	785	
Sample 786	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_39.raw	39	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	786	
Sample 787	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_40.raw	40	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	787	
Sample 788	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_41.raw	41	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	788	
Sample 789	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_42.raw	42	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	789	
Sample 790	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_43.raw	43	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	790	
Sample 791	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_44.raw	44	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	791	
Sample 792	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_45.raw	45	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	792	
Sample 793	Homo sapiens	NA	HEK293	NA	NA	NA	NA	Fetus	NA	20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_293_Rep1_46frac_46.raw	46	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	793	
Sample 794	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_1.raw	1	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	794	
Sample 795	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_2.raw	2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	795	
Sample 796	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_3.raw	3	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	796	
Sample 797	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_4.raw	4	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	797	
Sample 798	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_5.raw	5	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	798	
Sample 799	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_6.raw	6	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	799	
Sample 800	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_7.raw	7	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	800	
Sample 801	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_8.raw	8	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	801	
Sample 802	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_9.raw	9	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	802	
Sample 803	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_10.raw	10	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	803	
Sample 804	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_11.raw	11	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	804	
Sample 805	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_12.raw	12	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	805	
Sample 806	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_13.raw	13	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	806	
Sample 807	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_14.raw	14	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	807	
Sample 808	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_15.raw	15	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	808	
Sample 809	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_16.raw	16	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	809	
Sample 810	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_17.raw	17	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	810	
Sample 811	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_18.raw	18	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	811	
Sample 812	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_19.raw	19	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	812	
Sample 813	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_20.raw	20	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	813	
Sample 814	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_21.raw	21	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	814	
Sample 815	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_22.raw	22	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	815	
Sample 816	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_23.raw	23	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	816	
Sample 817	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_24.raw	24	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	817	
Sample 818	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_25.raw	25	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	818	
Sample 819	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_26.raw	26	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	819	
Sample 820	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_27.raw	27	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	820	
Sample 821	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_28.raw	28	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	821	
Sample 822	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_29.raw	29	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	822	
Sample 823	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_30.raw	30	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	823	
Sample 824	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_31.raw	31	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	824	
Sample 825	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_32.raw	32	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	825	
Sample 826	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_33.raw	33	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	826	
Sample 827	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_34.raw	34	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	827	
Sample 828	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_35.raw	35	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	828	
Sample 829	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_36.raw	36	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	829	
Sample 830	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_37.raw	37	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	830	
Sample 831	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_38.raw	38	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	831	
Sample 832	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_39.raw	39	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	832	
Sample 833	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_40.raw	40	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	833	
Sample 834	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_41.raw	41	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	834	
Sample 835	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_42.raw	42	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	835	
Sample 836	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_43.raw	43	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	836	
Sample 837	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_44.raw	44	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	837	
Sample 838	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_45.raw	45	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	838	
Sample 839	Homo sapiens	NA	SH-SY5Y	NA	NA	Femal	neuroblastoma	NA	NA	20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE3_UPLC8_DBJ_SA_SH-SY5Y_Rep1_46frac_46.raw	46	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	839	
Sample 840	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_1.raw	1	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	840	
Sample 841	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_2.raw	2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	841	
Sample 842	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_3.raw	3	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	842	
Sample 843	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_4.raw	4	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	843	
Sample 844	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_5.raw	5	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	844	
Sample 845	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_6.raw	6	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	845	
Sample 846	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_7.raw	7	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	846	
Sample 847	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_8.raw	8	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	847	
Sample 848	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_9.raw	9	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	848	
Sample 849	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_10.raw	10	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	849	
Sample 850	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_11.raw	11	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	850	
Sample 851	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_12.raw	12	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	851	
Sample 852	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_13.raw	13	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	852	
Sample 853	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_14.raw	14	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	853	
Sample 854	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_15.raw	15	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	854	
Sample 855	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_16.raw	16	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	855	
Sample 856	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_17.raw	17	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	856	
Sample 857	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_18.raw	18	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	857	
Sample 858	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_19.raw	19	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	858	
Sample 859	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_20.raw	20	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	859	
Sample 860	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_21.raw	21	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	860	
Sample 861	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_22.raw	22	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	861	
Sample 862	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_23.raw	23	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	862	
Sample 863	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_24.raw	24	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	863	
Sample 864	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_25.raw	25	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	864	
Sample 865	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_26.raw	26	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	865	
Sample 866	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_27.raw	27	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	866	
Sample 867	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_28.raw	28	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	867	
Sample 868	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_29.raw	29	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	868	
Sample 869	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_30.raw	30	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	869	
Sample 870	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_31.raw	31	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	870	
Sample 871	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_32.raw	32	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	871	
Sample 872	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_33.raw	33	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	872	
Sample 873	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151102_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_34_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151102_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_34_2.raw	34.2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	873	
Sample 874	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_35.raw	35	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	874	
Sample 875	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_36.raw	35	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	875	
Sample 876	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_37.raw	36	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	876	
Sample 877	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_38.raw	37	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	877	
Sample 878	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_39.raw	38	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	878	
Sample 879	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_40.raw	40	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	879	
Sample 880	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_41.raw	41	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	880	
Sample 881	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_42.raw	42	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	881	
Sample 882	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_43.raw	43	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	882	
Sample 883	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_44.raw	44	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	883	
Sample 884	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_45.raw	45	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	884	
Sample 885	Homo sapiens	NA	A549	NA	NA	male	lung adenocarcinoma	NA	NA	20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151023_QE4_UPLC5_DBJ_SA_A549_REP1_46frac_46.raw	46	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	885	
Sample 886	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_1.raw	1	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	886	
Sample 887	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_2.raw	2	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	887	
Sample 888	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_3.raw	3	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	888	
Sample 889	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_4.raw	4	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	889	
Sample 890	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_5.raw	5	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	890	
Sample 891	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_6.raw	6	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	891	
Sample 892	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_7.raw	7	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	892	
Sample 893	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_8.raw	8	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	893	
Sample 894	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_9.raw	9	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	894	
Sample 895	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_10.raw	10	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	895	
Sample 896	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_11.raw	11	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	896	
Sample 897	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_12.raw	12	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	897	
Sample 898	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_13.raw	13	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	898	
Sample 899	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_14.raw	14	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	899	
Sample 900	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_15.raw	15	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	900	
Sample 901	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_16.raw	16	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	901	
Sample 902	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_17.raw	17	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	902	
Sample 903	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_18.raw	18	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	903	
Sample 904	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_19.raw	19	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	904	
Sample 905	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_20.raw	20	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	905	
Sample 906	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_21.raw	21	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	906	
Sample 907	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_22.raw	22	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	907	
Sample 908	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_23.raw	23	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	908	
Sample 909	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_24.raw	24	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	909	
Sample 910	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_25.raw	25	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	910	
Sample 911	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_26.raw	26	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	911	
Sample 912	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_27.raw	27	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	912	
Sample 913	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_28.raw	28	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	913	
Sample 914	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_29.raw	29	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	914	
Sample 915	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_30.raw	30	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	915	
Sample 916	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_31.raw	31	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	916	
Sample 917	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_32.raw	32	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	917	
Sample 918	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_33.raw	33	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	918	
Sample 919	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_34.raw	34	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	919	
Sample 920	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_35.raw	35	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	920	
Sample 921	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_36.raw	36	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	921	
Sample 922	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_37.raw	37	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	922	
Sample 923	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_38.raw	38	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	923	
Sample 924	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_39.raw	39	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	924	
Sample 925	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_40.raw	40	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	925	
Sample 926	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_41.raw	41	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	926	
Sample 927	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_42.raw	42	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	927	
Sample 928	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_43.raw	43	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	928	
Sample 929	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_44.raw	44	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	929	
Sample 930	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_45.raw	45	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	930	
Sample 931	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE3_UPLC8_DBJ_SA_MCF7_Rep1_46frac_46.raw	46	patient 1	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	931	
Sample 932	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_1.raw	1	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	932	
Sample 933	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_2.raw	2	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	933	
Sample 934	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_3.raw	3	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	934	
Sample 935	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_4.raw	4	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	935	
Sample 936	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_5.raw	5	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	936	
Sample 937	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_6.raw	6	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	937	
Sample 938	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_7.raw	7	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	938	
Sample 939	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_8.raw	8	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	939	
Sample 940	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_9.raw	9	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	940	
Sample 941	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_10.raw	10	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	941	
Sample 942	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_11.raw	11	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	942	
Sample 943	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_12.raw	12	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	943	
Sample 944	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_13.raw	13	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	944	
Sample 945	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_14.raw	14	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	945	
Sample 946	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_15.raw	15	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	946	
Sample 947	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_16.raw	16	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	947	
Sample 948	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_17.raw	17	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	948	
Sample 949	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_18.raw	18	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	949	
Sample 950	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_19.raw	19	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	950	
Sample 951	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_20.raw	20	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	951	
Sample 952	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_21.raw	21	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	952	
Sample 953	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_22.raw	22	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	953	
Sample 954	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_23.raw	23	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	954	
Sample 955	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_24.raw	24	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	955	
Sample 956	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_25.raw	25	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	956	
Sample 957	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_26.raw	26	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	957	
Sample 958	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_27.raw	27	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	958	
Sample 959	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_28.raw	28	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	959	
Sample 960	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_29.raw	29	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	960	
Sample 961	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_30.raw	30	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	961	
Sample 962	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_31.raw	31	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	962	
Sample 963	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_32.raw	32	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	963	
Sample 964	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_33.raw	33	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	964	
Sample 965	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_34.raw	34	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	965	
Sample 966	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_35.raw	35	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	966	
Sample 967	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_36.raw	36	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	967	
Sample 968	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_37.raw	37	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	968	
Sample 969	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_38.raw	38	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	969	
Sample 970	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_39.raw	39	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	970	
Sample 971	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_40.raw	40	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	971	
Sample 972	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_41.raw	41	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	972	
Sample 973	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_42.raw	42	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	973	
Sample 974	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_43.raw	43	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	974	
Sample 975	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_44.raw	44	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	975	
Sample 976	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_45.raw	45	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	976	
Sample 977	Homo sapiens	NA	MCF-7	NA	NA	Female	breast cancer	NA	NA	20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20151028_QE5_UPLC10_DBJ_SA_MCF7_REP2_46frac_46.raw	46	patient 2	NE=Lys-C;AC=MS:1001309	NE=Trypsin；AC=MS:1001251	NM=Q Exactive;AC=MS:1001911	NM=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NM=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NM=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NM=Gln→pyro-Glu; MT=Variable; PP=Anywhere; AC=Unimod:27; TA=Q	NA	NA	NA	AC=MS:1002038;NM=label free sample	NA	NA	977	
